Short- and long-term effects of pulmonary rehabilitation for idiopathic pulmonary fibrosis: a systematic review and meta-analysis

被引:28
|
作者
Cheng, Li [1 ,2 ]
Tan, Botao [3 ]
Yin, Ying [3 ]
Wang, Sanrong [3 ]
Jia, Lang [3 ]
Warner, Gerry [4 ]
Jia, Gongwei [3 ]
Jiang, Wei [3 ]
机构
[1] Chongqing Med Univ, Affiliated Hosp 2, Dept Resp, Chongqing, Peoples R China
[2] Chongqing Med Univ, Affiliated Hosp 2, Dept Hlth Management Ctr, Chongqing, Peoples R China
[3] Chongqing Med Univ, Affiliated Hosp 2, Dept Rehabil, 76 Linjiang Rd, Chongqing 400010, Peoples R China
[4] Queen Elizabeth Hosp, Dept Rehabil, Bridgetown, Barbados
关键词
Pulmonary rehabilitation; idiopathic pulmonary fibrosis; exercise capacity; health-related quality of life; RESPIRATORY SOCIETY STATEMENT; QUALITY-OF-LIFE; VALIDATION; BENEFITS;
D O I
10.1177/0269215518779122
中图分类号
R49 [康复医学];
学科分类号
100215 ;
摘要
Objective: To investigate the short- and long-term effects of pulmonary rehabilitation in patients with idiopathic pulmonary fibrosis (IPF). Data sources: An electronic search of MEDLINE, Embase and Cochrane Central databases along with hand search of relevant papers were performed on 15 March 2018. Review methods: This study was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. We searched the literature for randomized controlled trials of pulmonary rehabilitation in IPF patients. The outcomes were exercise capacity and health-related quality of life. Two authors independently extracted data, assessed trial eligibility and risk of bias. Meta-analyses were performed using RevMan and STATA software. Results: We extracted data from four randomized controlled trials (142 participants). At short-term follow-up, pulmonary rehabilitation significantly enhanced 6-minute walk distance (6-MWD; weighted mean difference (WMD)=38.38, 95% confidence interval (CI)=4.64-72.12, I-2=60.7%; P<0.05), reduced St. George's Respiratory Questionnaire (SGRQ)/IPF-specific SGRQ (SGRQ-I) total score (WMD=-8.40, 95% CI=-11.44 to -5.36, I-2=0%; P<0.00001). At long-term follow-up, pulmonary rehabilitation could not enhance 6-MWD (WMD=17.02, 95% CI=-26.87 to 60.81, I-2=36.3%; P=0.43) or reduce SGRQ/SGRQ-I total score (WMD=-3.45, 95% CI=-8.55 to 1.64, I-2=38.3%; P=0.088). Conclusion: In patients with IPF, pulmonary rehabilitation showed short-term effects in enhancing exercise capacity and health-related quality of life, while it had no detectable effects at long-term follow-up.
引用
收藏
页码:1299 / 1307
页数:9
相关论文
共 50 条
  • [41] Prednisolone and Budesonide for Short- and Long-Term Treatment of Microscopic Colitis: A Systematic Review and Meta-Analysis
    Stewart, Michael
    Seow, Cynthia H.
    Storr, Martin
    GASTROENTEROLOGY, 2011, 140 (05) : S31 - S31
  • [42] Short- and long-term efficacy of adalimumab following infliximab failure: Systematic review and meta-analysis
    Ma, Christopher
    Panaccione, Remo
    Heitman, Steven
    Devlin, Shane
    Kaplan, Gilaad
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 : S450 - S450
  • [43] Prevalence and risk factors of sarcopenia in idiopathic pulmonary fibrosis: a systematic review and meta-analysis
    Li, Jiaye
    Lu, Ye
    Deng, Mingming
    Tong, Run
    Zhang, Qin
    Bian, Yiding
    Miao, Jinrui
    Wang, Zilin
    Zhou, Xiaoming
    Hou, Gang
    FRONTIERS IN MEDICINE, 2023, 10
  • [44] Effectiveness and Safety of Chinese Medicine for Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis
    Wu, Qi
    Zhou, Yao
    Feng, Fan-chao
    Zhou, Xian-mei
    CHINESE JOURNAL OF INTEGRATIVE MEDICINE, 2019, 25 (10) : 778 - 784
  • [45] Risk factors for acute exacerbation of idiopathic pulmonary fibrosis: A systematic review and meta-analysis
    Qiu, Meihua
    Chen, Yuqing
    Ye, Qiao
    CLINICAL RESPIRATORY JOURNAL, 2018, 12 (03): : 1084 - 1092
  • [46] SYSTEMATIC REVIEW AND NETWORK META-ANALYSIS OF APPROVED MEDICINES FOR THE TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS
    Skandamis, A.
    Kani, C.
    Souliotis, K.
    Markantonis, S.
    VALUE IN HEALTH, 2018, 21 : S231 - S231
  • [47] Danhong injection in the treatment of idiopathic pulmonary fibrosis A protocol for systematic review and meta-analysis
    Lan, Yanqiu
    Wu, Dezhi
    Jin, Yunrui
    Shui, Min
    Fan, Xianjun
    MEDICINE, 2020, 99 (37) : E22016
  • [48] Systematic Review and Meta-analysis of Pirfenidone, Nintedanib, and Pamrevlumab for the Treatment of Idiopathic Pulmonary Fibrosis
    Di Martino, Enrica
    Provenzani, Alessio
    Vitulo, Patrizio
    Polidori, Piera
    ANNALS OF PHARMACOTHERAPY, 2021, 55 (06) : 723 - 731
  • [49] Systematic review and network meta-analysis of approved medicines for the treatment of idiopathic pulmonary fibrosis
    Skandamis, Aristeidis
    Kani, Chara
    Markantonis, Sophia L.
    Souliotis, Kyriakos
    JOURNAL OF DRUG ASSESSMENT, 2019, 8 (01) : 55 - 61
  • [50] Treatment of Gastroesophageal Reflux in Patients With Idiopathic Pulmonary Fibrosis A Systematic Review and Meta-Analysis
    Fidler, Lee
    Sitzer, Nicole
    Shapera, Shane
    Shah, Prakesh S.
    CHEST, 2018, 153 (06) : 1405 - 1415